| Financial Year |
March 31 2023 |
| Monetary Funds |
714,366,533.82 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
88,955,798.07 |
| Accounts Receivable |
1,954,958,012.66 |
| Advances to Suppliers |
235,749,787.84 |
| Other Receivables |
7,155,847.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,186,157,216.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
154,217,036.20 |
| Total Current Assets |
4,770,170,099.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,541,148,237.48 |
| Under-construction Projects |
119,281,281.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,844,942.19 |
| R&D expenses |
-- |
| Goodwill |
5,343,267.81 |
| Long-Term Deferred and Prepaid Expenses |
273,752,363.49 |
| Deferred Income Tax Assets |
118,211,719.30 |
| Other Non-Current Assets |
245,185,497.91 |
| Sub-Total of Non-Current Assets |
2,354,078,101.06 |
| Total Assets |
7,124,248,200.63 |
| Short-Term Loans |
860,310,002.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,471,068,921.10 |
| Accounts Payable |
1,510,866,052.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,803,898.32 |
| Taxes Payable |
6,320,527.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
67,682,983.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
122,538,441.12 |
| Other Current Liabilities |
56,346,955.15 |
| Sub-Total of Current Liabilities |
4,136,007,467.72 |
| Long-term Loans |
174,588,097.26 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,643,230.96 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
96,001,971.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
397,959,958.40 |
| Total Liabilities |
4,533,967,426.12 |
| Paid-In Capital(Or Share Stock) |
328,040,025.00 |
| Capital Surplus |
1,241,031,191.17 |
| Surplus Reserve |
46,015,729.04 |
| LESS:Treasury Stock |
5,438,299.00 |
| Undistributed Profits |
983,968,962.19 |
| Minority Stockholder's Interest |
-2,313.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,590,283,087.91 |
| Owner's Equity（Stockholder's Equity） |
2,590,280,774.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,124,248,200.63 |
